GlassScriptPhysician profile
Patrick Wusok Yang
NPI 1649893355
$3,281.68
in general payments reported to CMS, 2019-2025
9 companies · $529 in 2025
The $529 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $38.68 · 2023: $228 · 2024: $2,486 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,668 · Travel and Lodging: $1,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,668.28 |
| Travel and Lodging | $1,574.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,421.45 | 2023-2024 | Ams 700, Tactra, Lithovue |
| Ferring Pharmaceuticals INC. | $206.44 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $147.45 | 2023-2024 | Jelmyto |
| Calyxo, INC. | $132.63 | 2025 | Cvac Aspiration System |
| Intuitive Surgical, INC. | $129.76 | 2025 | |
| Innovation Technologies INC | $123.26 | 2025 | Irrisept |
| Coloplast Corp | $67.23 | 2025 | |
| 180 Medical, INC. | $38.68 | 2022 | |
| Sumitomo Pharma America, INC. | $14.78 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.